PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-4.59%
Revenue decline while VET shows 12.64% growth. Joel Greenblatt would examine competitive position erosion.
-18.86%
Both companies reducing costs. Martin Whitman would check industry efficiency trends.
14.76%
Similar gross profit growth to VET's 17.82%. Walter Schloss would investigate industry dynamics.
20.28%
Margin expansion exceeding 1.5x VET's 4.59%. David Dodd would verify competitive advantages.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
20.38%
Other expenses change of 20.38% while VET maintains costs. Bruce Berkowitz would investigate efficiency.
-3.79%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-13.48%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
17.57%
D&A growth above 1.5x VET's 2.11%. Michael Burry would check for excessive investment.
25.76%
Similar EBITDA growth to VET's 26.38%. Walter Schloss would investigate industry trends.
46.17%
EBITDA margin growth exceeding 1.5x VET's 13.29%. David Dodd would verify competitive advantages.
53.69%
Operating income growth 1.25-1.5x VET's 48.15%. Bruce Berkowitz would examine sustainability.
61.07%
Operating margin growth exceeding 1.5x VET's 31.52%. David Dodd would verify competitive advantages.
26.97%
Other expenses growth above 1.5x VET's 16.63%. Michael Burry would check for concerning trends.
100.09%
Pre-tax income growth below 50% of VET's 539.87%. Michael Burry would check for structural issues.
109.71%
Pre-tax margin growth below 50% of VET's 490.51%. Michael Burry would check for structural issues.
247.44%
Tax expense growth above 1.5x VET's 72.14%. Michael Burry would check for concerning trends.
-13.75%
Net income decline while VET shows 890.31% growth. Joel Greenblatt would examine position.
-9.61%
Net margin decline while VET shows 779.18% growth. Joel Greenblatt would examine position.
-13.92%
EPS decline while VET shows 100.00% growth. Joel Greenblatt would examine position.
-12.26%
Diluted EPS decline while VET shows 100.00% growth. Joel Greenblatt would examine position.
-24.01%
Share count reduction while VET shows 0.80% change. Joel Greenblatt would examine strategy.
-24.17%
Diluted share reduction while VET shows 1.37% change. Joel Greenblatt would examine strategy.